A buyer-oriented shortlist for nuclear medicine. Confirm exact intended use and local validation needs
before any pilot or procurement decision.
Turn this list into an evaluation
Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.
Does the exact authorized role match the clinical task you want to evaluate?
Do the population, inputs and study endpoint match the proposed use?
What will your team test locally, and who owns failures and rollback?
Authorized purpose: uMI Panvivo variants acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, attenuation correction, and the labeled body-region workflows.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Authorized purpose: uMI Panvivo PET/CT acquires anatomical CT and functional PET images of radiopharmaceutical distribution for qualified diagnostic and treatment-planning workflows, including labeled lung-cancer-screening use.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, head and neck, cardiac, and other labeled PET/CT regions
Authorized purpose: BIOGRAPH One with syngo MR XB10 combines metabolic or physiologic PET information with MR anatomy, MR-based attenuation correction, fused alignment, and support for treatment planning and interventions.
Authorized purpose: TruSPECT Processing Station receives, transfers, displays, stores, and processes radioisotope-tracer images for trained professionals; TruClear AI SPECT enhancement supports the existing image-processing workflow and does not replace clinical judgment.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Heart, organs, and body regions represented in SPECT studies
Authorized purpose: Cartesion Prime PET/CT acquires cross-sectional CT images and PET radiopharmaceutical-distribution images and includes AiCE-i PET processing and a neural-network respiratory-gating workflow for supported examinations.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, head, neck, cardiac, and other labeled PET/CT regions
Authorized purpose: Voxel Dosimetry 3.1 calculates voxel-level absorbed-dose maps from nuclear-medicine images acquired after administration of FDA-approved therapeutic radiopharmaceuticals and supports single-time-point or time-series workflows.
Authorized purpose: uMI Panvivo and Panvivo S acquire and display PET and CT information for anatomical and functional imaging, radiopharmaceutical distribution, and the labeled oncology, cardiology, neurology, infection, inflammation, radiotherapy-planning, and interventional workflows.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body; brain; head and neck; heart; lung; breast; gastrointestinal; urinary; genital; and musculoskeletal anatomy
Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF provide PET, SPECT, nuclear-medicine, CT, and MR viewing, manipulation, quantification, longitudinal comparison, and analysis for oncology, cardiology, neurology, organ function, and selected radiation-planning support.
Authorized purpose: Opulus Lymphoma Precision segments and visualizes lesions and measures total metabolic tumor volume in whole-body FDG-PET/CT for patients already diagnosed with FDG-avid lymphoma; trained physicians can accept/reject annotated output, but radiologist review makes the final interpretation and the device is not a screening/diagnostic substitute.
Authorized purpose: Clarify DL is a deep-learning reconstruction function intended to reduce noise and improve image quality of nuclear-medicine bone SPECT scintigraphy for all ages on the supported Xeleris V and StarGuide platforms.
Authorized purpose: The uMI Panvivo PET/CT system provides anatomical and functional images. PET depicts the distribution of approved radiopharmaceuticals and CT provides diagnostic tomographic and photon-attenuation information. The FDA indication describes qualified-professional use for detection, localization, evaluation, diagnosis, staging, restaging, monitoring, and follow-up in oncology, infection and inflammation, neurology, and other labeled workflows, plus radiotherapy planning, interventional radiology, and protocol-constrained low-dose lung-cancer screening.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and regional anatomy represented in PET/CT studies
Authorized purpose: Quantitative single-timepoint or longitudinal analysis of lesion ROIs on adult PET/CT, including volume, density, and tracer-uptake changes, with a report used as an adjunct to local image interpretation.
Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation. K241585 adds reconstruction, respiratory-motion, CT-less attenuation-correction, quantitative-normalization, quality-control, and AI-expanded-field-of-view functions.
Authorized purpose: syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Authorized purpose: The uMI Panvivo is a PET/CT system for anatomical and functional images. PET provides distribution information for approved radiopharmaceuticals and CT provides diagnostic tomographic anatomy and photon attenuation information. The FDA material describes qualified-professional assessment of metabolic and physiologic functions and labeled detection, diagnosis, staging, monitoring, follow-up, radiotherapy-planning, and interventional workflows.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and regional anatomy represented in PET/CT studies
Omni Legend is a PET/CT system for attenuation-corrected PET with positron-emitting radiopharmaceuticals across whole-body, head, heart, brain, lung, breast, bone, gastrointestinal, lymphatic, and other organ workflows; CT can be used for diagnosis, planning, and image fusion.
Authorized purpose: The uPMR 790 combines MR and PET devices to provide registered and fused high-resolution physiologic and anatomic information acquired simultaneously and isocentrically. The FDA indication describes independent MR and PET functionality, MR images of the head, body, and extremities, PET radiopharmaceutical distribution, MR-based attenuation correction, and fused PET/MR reference.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Head, body, and extremities represented in fused PET/MR studies
Authorized purpose: The Biograph VK10 combines X-ray CT and PET to register and fuse anatomic and physiologic information, supports independent CT or PET imaging, and aids trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function; the CT may also support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.
Authorized purpose: Cartesion Prime is a PET/CT system for acquisition, reconstruction, fusion, visualization, and professional interpretation within the cleared configuration and radiopharmaceutical workflow.
Authorized purpose: uMI Panorama GS combines 148 cm axial-field-of-view PET with CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and registered or fused PET/CT images supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation in oncology, cardiology, neurology, inflammation, infection, and other disorders. The CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.
Authorized purpose: The Biograph Vision.X and Biograph Vision.X Edge combine X-ray CT and PET to register and fuse anatomic and physiologic information, support independent CT or PET imaging, aid trained professionals in detecting, localizing, diagnosing, staging, and restaging disease, lesions, tumors, and organ function, and support radiotherapy planning, interventional procedures, and low-dose lung-cancer screening in high-risk populations.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, cardiovascular, neurological, oncologic, and organ-function imaging
Precision DL uses deep-learning image processing to enhance non-time-of-flight F-18 FDG PET images for clinical oncology review in adults and children.
Authorized purpose: uMI Panorama combines PET and CT to provide quantitative radiopharmaceutical distribution, diagnostic anatomical and attenuation information, and fused PET/CT images for qualified healthcare professionals supporting detection, localization, diagnosis, staging, restaging, treatment planning, and treatment-response evaluation across oncology, cardiology, neurology, and other disorders; its CT subsystem can also perform standalone diagnostic imaging and protocol-governed low-dose lung cancer screening.
Authorized purpose: The Xeleris V Processing and Review System displays, processes, archives, prints, reports, and networks planar, SPECT, and PET nuclear-medicine data, with optional applications for DaTQUANT, lung analysis, brain analysis, coronary-flow reserve, prostate-cancer bone metastases, liver shunt and dose calculations, and monitoring of patient radiation doses from nuclear-medicine imaging data.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body, lung, brain, liver, cardiac, coronary, and other anatomy represented in labeled nuclear-medicine studies
Authorized purpose: aPROMISE X accepts, stores, displays, manipulates, quantifies, and reports digital medical images from nuclear-medicine imaging using PSMA PET/CT, with tools for marking regions of interest and quantitative oncology review by healthcare professionals or researchers.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body oncology anatomy represented in PSMA PET/CT studies
SubtlePET is DICOM image-processing software that reduces noise in FDG, amyloid, 18F-DOPA, 18F-DCFPyL, Ga-68 Dotatate, and Ga-68 PSMA PET images for radiologist or nuclear-medicine-physician review.
Authorized purpose: Discovery MI Gen2 acquires and displays PET/CT images of radiopharmaceutical distribution and anatomical structures for qualified nuclear-medicine and radiology professionals within the labeled imaging workflow.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and organs represented in Discovery MI PET/CT studies
Authorized purpose: TruSPECT Radiological Image Processing Station receives, transfers, displays, stores, and processes radioisotope-tracer images for trained professionals in the labeled SPECT workflow.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Heart and other organs represented in SPECT studies
Authorized purpose: Vereos PET/CT detects, localizes, diagnoses, stages, restages, and follows treatment response in oncology, cardiology, and neurology and can provide diagnostic CT and radiotherapy-planning support; optional PET Adaptive Reconstruction is an AI-powered image-reconstruction function.
Authorized purpose: aPROMISE is a cloud-based platform for healthcare professionals and researchers to accept, transfer, store, display, manipulate, quantify, and report PSMA PET/CT examinations using the PROMISE framework.
Authorized purpose: HYPER AiR provides the cleared nuclear-medicine image-processing support described in K210001 for supported PET/CT studies; outputs require review by qualified professionals and do not establish product-wide clinical performance.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole body and organs represented in supported PET/CT studies
Authorized purpose: Cartesion Prime is a PET/CT system for acquisition, reconstruction, fusion, visualization, and professional interpretation within the cleared configuration and radiopharmaceutical workflow.
Authorized purpose: syngo.via molecular-imaging workflows provide viewing, manipulation, quantification, analysis, and comparison of medical images from one or more modalities and time points, including PET or nuclear-medicine functional data and CT or MR anatomical data. The workflows support disease-management activities in oncology, cardiology, neurology, and organ function, and the images or results may aid radiotherapy treatment planning. The submission also describes Scenium neurology review and syngo MBF quantitative myocardial-blood-flow review for supported PET studies.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, cardiac, neurologic, oncologic, organ-function, and radiotherapy-planning anatomy represented in PET, nuclear-medicine, CT, and MR studies
Authorized purpose: Xeleris V is intended for nuclear-medicine or radiology practitioners and referring physicians to display, process, archive, print, report, and network nuclear-medicine data from gamma cameras or PET scanners. PET or nuclear-medicine data may be registered or fused with CT or MR and physiologic signals to depict, localize, or quantify radionuclide tracers and anatomical structures. The labeled applications include DaTQUANT review of 123I-ioflupane images, Q.Lung support for pulmonary embolism, COPD, emphysema, lung-function assessment, and resection planning, and Q.Brain review of brain metabolic function or blood flow in specified neurologic conditions.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body, lung, brain/striatum, and other anatomy represented in nuclear-medicine, PET, CT, and MR studies
Authorized purpose: HYPER DLR is an image-processing function intended for radiologists and nuclear-medicine physicians to reduce noise in fluorodeoxyglucose PET images. The software is intended to be implemented on the previously cleared uMI 550 and uMI 780 PET/CT devices.
Authorized purpose: The Biograph Vision and Biograph mCT family are combined PET/CT systems for acquiring, reconstructing, fusing, displaying, evaluating, and archiving PET and CT studies for trained nuclear-medicine and radiology professionals across labeled oncology, cardiology, neurology, and radiotherapy-planning workflows.
Authorized purpose: Biograph Horizon is a PET/CT system for the labeled molecular-imaging acquisition, reconstruction, fusion, visualization, and professional-interpretation workflow.
Authorized purpose: aBSI analyzes nuclear-medicine whole-body bone scans and SPECT to mark lesions and quantify skeletal disease burden as a fraction of total skeletal weight for trained professionals and researchers; the cloud release does not accept CT or static partial bone scans.
Authorized purpose: SubtlePET V1.0.0 is image-processing software for transfer, storage, and noise reduction of FDG and amyloid PET images, including PET/CT and PET/MR studies.
Modality
PET/SPECT/Nuclear Medicine
Anatomy
Whole-body and brain PET imaging regions, including FDG and amyloid PET studies